Emactuzumab (Anti-CSF1R / M-CSFR / CD115) | Read Reviews & Product Use Citations

Emactuzumab (Anti-CSF1R / M-CSFR / CD115) is a humanized monoclonal antibody directed against the tyrosine kinase receptor colony stimulating factor 1 receptor (CSF1R, CSF-1R, CD115), also known as macrophage colony-stimulating factor receptor (M-CSFR), with potential antineoplastic and immunomodulating activities MW : 146.94 KD.

Purity & Quality Control

Batch: A285101 Purity: 99% Protein concentration: 19.01mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Emactuzumab (Anti-CSF1R / M-CSFR / CD115) is a humanized monoclonal antibody directed against the tyrosine kinase receptor colony stimulating factor 1 receptor (CSF1R, CSF-1R, CD115), also known as macrophage colony-stimulating factor receptor (M-CSFR), with potential antineoplastic and immunomodulating activities MW : 146.94 KD.

References
[1] Cassier PA, et al. Lancet Oncol. 2015;16(8):949-956.

References

[1] Cassier PA, et al. Lancet Oncol. 2015;16(8):949-956.

Product Details

CAS No.	1448221-67-7
Molecular Weight	146.94
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field